Cargando…
Exploring the therapeutic potential of modern and ancestral phenylalanine/tyrosine ammonia-lyases as supplementary treatment of hereditary tyrosinemia
Phenylalanine/tyrosine ammonia-lyases (PAL/TALs) have been approved by the FDA for treatment of phenylketonuria and may harbour potential for complementary treatment of hereditary tyrosinemia Type I. Herein, we explore ancestral sequence reconstruction as an enzyme engineering tool to enhance the th...
Autores principales: | Hendrikse, Natalie M., Holmberg Larsson, Albin, Svensson Gelius, Stefan, Kuprin, Sergei, Nordling, Erik, Syrén, Per-Olof |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6987202/ https://www.ncbi.nlm.nih.gov/pubmed/31992763 http://dx.doi.org/10.1038/s41598-020-57913-y |
Ejemplares similares
-
Fungal and Plant Phenylalanine Ammonia-lyase
por: Hyun, Min Woo, et al.
Publicado: (2011) -
Genomic Characterization of Phenylalanine Ammonia Lyase Gene in Buckwheat
por: Thiyagarajan, Karthikeyan, et al.
Publicado: (2016) -
Ancestral lysosomal enzymes with increased activity harbor therapeutic potential for treatment of Hunter syndrome
por: Hendrikse, Natalie M., et al.
Publicado: (2021) -
Purification and Characterization of Phenylalanine Ammonia Lyase from Trichosporon cutaneum
por: Goldson-Barnaby, Andrea, et al.
Publicado: (2013) -
Saturation Mutagenesis for Phenylalanine Ammonia Lyases of Enhanced Catalytic Properties
por: Tomoiagă, Raluca Bianca, et al.
Publicado: (2020)